Join us today at 12 p.m. ET as CEO @drsmusunuri talks with #TitanPartners about our pipeline progress and upcoming milestones for #OCU410, #OCU410ST, and #OCU400. Don’t miss this discussion about the potential of modifier gene therapy. To join, click bit.ly/49L9lpN.
On this #VeteransDay, we honor the heroism of the men and women who served to protect our freedoms. Your strength and courage inspire us to continue our commitment to making a meaningful impact in people’s lives. Thank you for your bravery.
Mobile Optimization update. We have fixed several bugs and issues on mobile. - Wallet Connect should work always - No log out issues - Overall better
In @ThePharmaSource, Ocugen’s CSO shares insight into the novel approach of modifier gene therapy to address large patient populations, along with updates on the Company’s progress toward 3 BLAs in 3 years. Read more: bit.ly/3LJP0Y0 #Ocugen #GeneTherapy
$ocgn load up for the many partnership PR’s to come. Then hold for the 3 BLA’s and billions in revenue. A bio with a $400M market cap with 3 mega blockbuster drugs lined up for BLA year after year after year. Trial data shows 100% efficacy, 100% safety. Where this investment is…
🤯 JPMorgan just disclosed $1.32M in $BYND call options. They know something - and they’re betting big. The setup is getting unreal. 🚀
Happy to share 3Q business highlights!! Thank you team @Ocugen!
Read the latest from @FrontNeurosci! Our authors share how nuclear hormone receptors including RORA could potentially open new doors for #Autism treatment. RORA modifier #genetherapy is in clinical development for dAMD and Stargardt diseases. Read more: bit.ly/47yTEiP
Encouraging to show that our gene therapy in clinical trials for dAMD and Stargardt has potential to target Autism - high unmet medical need @autismspeaks
CEO @drsmusunuri shared our 3Q 2025 results today! We are advancing all our clinical programs and strengthening our cash position, remaining on track to file three BLAs in three years. 🔗bit.ly/4997lYt @FightBlindness @macular_org #Genetherapy #Biotech #Ocugen
October was full of celebration and teamwork! From Diwali festivities to Halloween fun, we were reminded that collaboration and community help us perform our best for patients facing vision loss. #Ocugen #TeamBuilding #Culture
October Wrap up at Ocugen!!
We are now enrolling patients as young as 3 in our OCU410ST Phase 2/3 GARDian3 clinical trial for #Stargardtdisease. Phase 1 data shows 100% stabilization or improvement in treated eyes and 48.2% slower lesion growth. Learn more: [email protected] #OCU410ST #Ocugen
We are now enrolling patients as young as 3 in our OCU410ST Phase 2/3 GARDian3 clinical trial for #Stargardtdisease. Phase 1 data shows 100% stabilization or improvement in treated eyes and 48.2% slower lesion growth. Learn more: [email protected] #OCU410ST #Ocugen
$OCGN Hieu Tran's personal story: He invests in Ocugen because his grandfather's vision loss motivated him to find a company that could help others see again. A promise he couldn't keep, now a mission. #Ocugen #VisionCare
✅ Spot Trading: Du kaufst mit deinem eigenen Kapital – 1:1, kein Leverage. Geeignet für langfristige Strategien und geringeres Risiko. ⚡ Margin Trading: Du handelst mit geliehenem Kapital – auf Bitpanda mit bis zu 10x Leverage. Geeignet für kurzfristige Trades mit mehr…
Ocugen’s paper on #OCU400, our AAV5-based gene therapy for #retinitispigmentosa, is now published in @FrontiersIn! This study supported our Phase 1/2 IND. OCU400 is now in Phase 3. Read: bit.ly/4oB8MTG #Biotech #Ocugen #GeneTherapy
$OCGN Ocugen Investors Brace for Pivotal November Update ad-hoc-news.de/boerse/news/ue…
United States Trends
- 1. Bama 17.8K posts
- 2. #UFC322 32.5K posts
- 3. Oklahoma 27.1K posts
- 4. Ty Simpson 3,692 posts
- 5. Jeremiah Smith 1,655 posts
- 6. Boomer Sooner 1,934 posts
- 7. Wingo N/A
- 8. Iowa 19K posts
- 9. Mateer 3,135 posts
- 10. Sabatini 1,339 posts
- 11. Brent Venables 1,325 posts
- 12. #AEWCollision 2,792 posts
- 13. #RollTide 3,207 posts
- 14. Jungkook 253K posts
- 15. Eubank 42K posts
- 16. Heisman 10.9K posts
- 17. Kyle Daukaus N/A
- 18. UConn 4,291 posts
- 19. Kline 1,577 posts
- 20. DeBoer 1,449 posts
Something went wrong.
Something went wrong.